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Introduction. The paper presents an original, used in our Institute, method of lung volume irradiation in patients with 
pneumonia during COVID-19 infection.
Material and methods. Procedures such as the simulation of treatment and radiotherapy are performed in a treatment 
room. Real time radiation treatment planning is realized as 2D planning (Irreg Planning VMS) in a separate room, and the 
3D (eclipse VMS) dose distribution is calculated after the treatment. During radiation exposure, a fluence map is measured. 
Results. A method of irradiating the lungs of patients with COVID-19 was developed, which allows to shorten the time 
the patient is on the treatment table and minimize contacts between the patient and staff.
Conclusions. The presented procedure made it possible to minimize the time of patient’s stay in the radiotherapy depart-
ment and at the same time, it retains all the required quality assurance procedures in radiotherapy treatment.
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Introduction
The use of ionizing radiation in the treatment of pneumonia 
and other inflammatory conditions has a long tradition 
[1–3]. In contemporary literature [4–7], information can be 
found on the use of low-dose rate radiotherapy in the tre-
atment of inflammation, including pneumonia. The current 
pandemic situation is characterized by the dramatic course 
of pneumonia among certain COVID-19 patients and the 
relatively high percentage of deaths due to lung failure in 
this group. Therefore, the question should be raised as to 
whether low-dose radiotherapy can become a treatment 
method that gives a chance to improve the quality of life 
and reduce the risk of death for such patients. Such a tre-
atment protocol should determine a radiation dose per 
lung volume area [8–10] and be positively assessed by the 
Bioethics Committee. 
Objective
The aim of this paper is to present a unique and proprietary 
procedure of lung radiotherapy in pneumonia patients during 
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download 
articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
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the course of COVID-19 infection with particular emphasis on 
the physical aspects of treatment planning and dosimetry. 
The duration of the procedure (planning and treatment) should 
be as short as possible.
1. The place of the procedure should be limited to a mini-
mum number of rooms. The irradiation session should be 
image guided. 
2. The target area refers to the irradiated volume, namely the 
patient’s lungs. The only organ shielded is the spinal canal. 
3. The dose distribution should be presented in 3D.
Based on pre-clinical and clinical studies [8–10], a dose in 
the range: 0.5–1.5 Gy is considered to have anti-inflammatory 
properties. Given this, the mean dose in this procedure was 
set at 1 Gy in whole lungs volume. 
Material and methods
Considering the epidemic risk, it was assumed that the patients 
should be admitted to the Radiotherapy Department through 
a separate entrance, so as not to cross communication routes 
dedicated to oncological patients and medical staff. Additio-
nally, both radiotherapy preparation and treatment should 
take place in a combined complex of rooms isolated from 
other patients and staff. 
One of the TrueBeam Varian Medical Systems (VMS) ac-
celerators was installed near the service entrance to the RT 
Department. It is equipped with an OBI (On-Board Imager): 
CBCT and kV/MV imaging. Software Irreg Planning, is an in-
tegrated part of the Aria System (16.1.0) VMS, which makes it 
possible to calculate the treatment time (MU – monitor units) 
based on the size of the irradiation field (beam), source skin 
distance (SSD) and the depth of the planning dose definition. 
Therefore, the MUs is calculated for a density of 1 g/cm3. When 
this software (Irreg Planning) is used in the irradiation of the 
chest volume, the calculated treatment time is overstated. This 
software (2D planning) is used for clinical purposes during 
simulation in cases where it is particularly important to shorten 
the preparation time of patients to radiotherapy e.g., analgesic 
therapy. In the case of a single irradiation session, a CT scan is 
not required to be performed. 
It was assumed that the calculated dose distribution would 
be three-dimensional, in order to assess the statistical dose in 
the lungs and critical organs: the heart and the spinal cord. 
The TrueBeam accelerator is equipped with both kV and MV 
(on board imager – OBI) imaging systems; CBCT is a routine 
procedure to verify the patient’s position before a therapeutic 
session. Until now, this study has not been used to plan dose 
distributions. In this case, however, in order to shorten the 
overall duration of the treatment procedure, CBCT was used 
to calculate the dose distribution.
With regard to the clear reduction of the procedure time, 
it was decided that treatment would be carried out using the 
TrueBeam VMS. The following procedure stages were deve-
loped (fig. 1):
1. The patient is placed in a therapeutic position on the table 
of the therapeutic apparatus.
2. With the use of kV (X-ray) imaging, the irradiation condi-
tions are simulated by defining the maximum dimensions 
of the therapeutic beam. The AP (anterior-posterior) di-
mension is defined in the transverse largest dimension at 
lung level. Based on this measurement, the depth (half AP 
dimension) of prescribed dose is determined.
patient arrival at the RT department
staff: the infectious disease hospital team
patient positioning on the therapeutic table in 
the treatment room
staff: technicians of the RT department 
procedure duration: 10 min.
simulation of treatment conditions
staff: technicians of the RT department 



















omdefining the beam shape and calculating the 
irradiation time
staff: medical physicists and a radiotherapist
procedure duration: 10 min.
irradiation; radiotherapy session
staff: technicians of the RT department 
procedure duration: 3 min.
CBCT examination
staff: technicians of the RT department 
procedure duration: 5 min.
patient release from the therapeutic table
staff: technicians of the RT department 
procedure duration: 5 min.
patient return to the infectious disease hospital
staff: the infectious disease hospital team
3D planning treatment based on CBCT examination 
with real beam geometry and irradiation time
staff: medical physicists
procedure duration: 45 min.
Figure 1. A schematic diagram of patient irradiation procedures. The 
time the patient stays in the therapeutic position on the table is 30 
minutes. The total stay in the RT Department is limited to 45 minutes
240
3. Based on the simulation image (one, at an angle of 0°) in 
the Irreg Planning software, MLC is introduced – limiting 
the irradiation area to the contour of the lungs with the 
spinal canal being shielded (the MLC collimator should be 
set at 90°). After copying the field shape defined in this way 
to the opposite beam, at an angle of 180°, the software 
adjusts the position of the collimator leaves to the new 
irradiation angle. The irradiation time is calculated.
4. The treatment planning (2D) process is completed by 
entering the beam parameters (i.e. MU, MLC, table, gantry, 
collimator position) into the patient management system 
(ARIA). 
5. The patient is irradiated and the fluence map is measu-
red by EPID., and at the end of exposure, a CBCT scan is 
performed. 
6. The patient completes the treatment and is taken back to 
their hospital base.
7. Dose distribution calculations (3D) are performed for the 
implemented radiation conditions, i.e., the shape of the 
radiation beam and exposure time. This stage is designed 
to accurately determine the dose received by the patient 
in the volume of each defined area.
Dosimetric preparation
The Irreg Planning software does not consider the heteroge-
neity of the irradiated medium, and thus the actual radiation 
dose in this volume can be expected to be higher, since the 
lung density is less than the water density – 1 g/cm3. That is 
why it should be verified by calculations based on CT scans. 
The precise calculation of dose distributions requires the 
introduction of the calibration curve of the device used for 
imaging into the treatment planning system (TPS-Eclipse 
VMS 16.01.03). In this case, it was the OBI-CBCT device of 
the TrueBeam accelerator. Unfortunately, this proved to be 
difficult to implement, and thus the differences were checked 
between the dose distribution calculations made with CT 
scans for routine treatment planning and CBCT, using the 
reference calibration curve (fig. 2). For this purpose, phan-
toms were utilized to calibrate the CT scanner (CIRS-Norfolk, 
Virginia, USA). Due to the slight differences between the 
calculations: maximum dose, the examination performed 
with a calibrated CT scanner – 2.173 Gy, and for CBCT, with 
a reference calibration curve – 2.176 Gy, it was found that 
it was possible to perform dose calculations for the patient 
using the CBCT scanner.
Before the first treatment procedure, all the steps descri-
bed above were taught to the staff (RT technicians, medical 
physicists). It was established that in order to optimize the 
duration of the treatment, the patient’s irradiation procedure 
should be carried out first; only at the end of exposure should 
a conical CT scan be performed. The width of the area that can 
be examined during one CT scan is 20 cm. Since the examined 
lung volume is a much larger area, two CBCT scans need to be 
performed so that they can be later combined to determine 
the entire lung volume needed for calculation. This requires 
changing the centering points, which involves moving the the-
rapy table. The CBCT scan is performed in the SAD technique 
and the patient is treated in the SSD technique. This requires 
changing the position of the therapy table.
The first patient
The patient was admitted to the RT Department on December 
15th, 2020 at 5:12 pm. A 50-year-old woman with COVID-19 
(based on a real time polymerase chain reaction of SARS-CoV-2 
RNA) has been admitted to the hospital with symptoms and 
radiographic pneumonic consolidations of COVID-related 
pneumonia. 96 hours after admission, an RT procedure was 
carried out. Oxygen saturation level [SpO2] with O2 supplemen-
tation via facial mask with reservoir bag was 88% prior to RT.
The first procedure involved placing the patient on a the-
rapeutic table in the treatment position – on their back with 
their hands along their body and head supported (part of the 
AiO system – ORFIT company). No immobilization systems 
were used. A simulation image was produced using the MV 
beam. Then, the shape of the irradiation field was defined by 
determining the lung area by placing the collimator leaves 
Figure 2. A comparison of phantom dose distributions with different densities. A. CT scans obtained by a CT scanner dedicated for treatment planning 
(AS-Siemens), a calibration curve introduced into the treatment planning system; B. scans obtained by a therapeutic device, with CBCT. Dose distribution 
calculations were made with the use of the treatment planning system Eclipse v 16.1.0 by Varian Medical Systems based on the reference calibration 
curve
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on the image obtained in the MV examination. Finally, the 
irradiation field determined at an angle of 0° was copied to 
the opposite beam at an angle of 180° by adjusting the shape 
of MLC (fig. 3).
The next stage involved calculating the irradiation time, 
for a dose of 1 Gy, at a depth equal to ½ of the AP (anterior – 
posterior; in this case, it was 13.7 cm). The X-ray beam of 6 MV 
was applied and the SSD technique (100 cm) was used. The 
calculations were performed using the Irreg Planning 16.1.0 
software by Varian Medical Systems [11], which is dedicated 
to calculations in 2D planning. 
The patient was irradiated and a CBCT scan was performed 
at the end of the exposure. Due to the maximum volume that 
can be obtained in one CBCT rotation, two scans had to be 
performed, moving them relative to each other to cover the 
entire lungs.
During radiation exposure, a fluence map was measured 
on the extended EPID (Electronic Portal Imaging Devices) using 
the integrated dose option of the Varian Medical Systems’ ARIA 
16.1.0 software for both 0° and 180° radiation beams. The pa-
tient left the Radiotherapy Department at 5:50 pm. The whole 
described procedure lasted 38 minutes in total. However, the 
patient was on the therapeutic table, in the treatment position 
for only 20 minutes.  
The 3D dose distribution planning, based on CBCT, is per-
formed without the patient’s presence in the RT Department. 
The dose distribution (3D) is calculated in the Eclipse v 16.1.0 
VMS planning system, for irradiation time and beam geometry 
predefined in the Irreg Planning – ARIA VMS software (fig. 4). 
It is worth emphasizing at this point once again that this 
procedure is performed without the presence of the patient 
in the RT Department. It aims to precisely determine the dose 
received by the patient as the dosage calculation algorithm 
(Acuros 16.1.0-VMS) considers the actual tissue density obta-
ined from CBCT. 
The calculated dose distributions (Acuros algorithm 16.1.0--
VMS), considering heterogeneity in density, indicate that the pa-
tient received an average dose of 1.091 Gy in the lungs. The ave-
rage dose in the lungs was found to be higher than assumed, 
since the time calculated in the Irreg Planning option was for 
a medium with a density of 1g/cm3, while, in fact, lung tissue 
has a lower density. This makes the actual doses slightly higher. 
The modal dose in the spinal cord was 0.016 Gy. These differen-
ces do not exceed the therapeutic assumptions and significantly 
shorten the duration of the entire treatment procedure.
24 hours after the RT procedure, an increase in SatO2 was 
noticed and continued over the next days. 24 hours after 
RT, there was also significant decrease in CRP, IL6 and ferritin 
Figure 3. A simulation image with a prepared beam shape – MLC, beam 
entry at an angle of 0°. One should remember to set the collimator 
angle to 90°; to use the collimator leaves to shield the spinal canal 
(the direction of the collimator leaves’ movement). The position of the 
collimator leaves is copied to the opposite beam at an angle of 180°
Figure 4. Dose distributions calculated for beam geometry: shapes and the number of monitoring units previously calculated in the Irreg Planning-VMS 
software 16.1.0
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level (tab. I). Clinically, improvement started 24 hours after RT 
and continued to the state that the patient was discharged 
from the hospital 14 days later with their overall status being 
very good.
Conclusions
The presented procedure of lung irradiation in patients with 
pneumonia during the course of COVID-19 infection made it 
possible to minimize the patient’s stay in the Radiotherapy 
Department. At the same time, it ensures all the required 
radiotherapy treatment quality assurance procedures are ad-
hered to. The dose received by the patient was consistent 
with the therapeutic requirements. The irradiation process 
was controlled from both a dosimetric (a fluence map) and 
an imaging (real-time MV imaging) perspective. The proce-
dure also involved the calculation of three-dimensional dose 
distribution, which allows for the presentation of full statistics 
of dose distribution to the critical organs (spinal cord, heart). 
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Table I. The change of biochemical parameters in the selected days after RT
Marker/day 0 1 5 7 14
Sat 88% 90% 94% 97% 92%
CRP 166.73 7.68 2.47 1.58 1.58
Ferrytyna 2453 685.52 783.95 601.95 556.76
IL6 23.38 2.04 3.06 2.19
Sat – oxygen saturation; CRP – C-reactive protein; IL6 – interleukin 6
